| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |